The virus establishes a lifelong latent infection in CD34+ haematopoietic stem and progenitor cells (HSPCs) and myeloid lineage cells within the human host, typically remaining asymptomatic unless immune surveillance is compromised. This evidence concerns the gene CD34 and disease arising from reactivation of latent virus.